文献速递肺外科

肥胖患者肺癌手术选择电视辅助胸腔镜手术还是开胸手术?欧洲胸外科医师学会数据库分析

Video-assisted thoracic surgery or thoracotomy for lung cancer surgery in obese patients? An analysis of the European Society of Thoracic Surgeons database.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该研究基于欧洲胸外科医师学会数据库2007至2021年连续病例,纳入体重指数≥30、接受肺叶切除术的非小细胞肺癌肥胖患者13999例(电视辅助胸腔镜手术5562例,开胸8437例),采用意向性治疗分析,比较两种术式的并发症率、死亡率和术后住院时间。结果显示电视辅助胸腔镜手术组并发症率、死亡率和术后住院时间均低于开胸组,倾向性评分匹配后并发症率和术后住院时间仍较低,重度肥胖和病态肥胖亚组结果一致。

要点

  • 肥胖非小细胞肺癌患者中,电视辅助胸腔镜肺叶切除术较开胸术并发症率更低(23.2% vs 30.2%,P < 0.001)。
  • 电视辅助胸腔镜组死亡率低于开胸组(0.8% vs 1.5%,P < 0.001),术后住院时间更短(中位5天 vs 7天,P < 0.001)。
  • 倾向性评分匹配后电视辅助胸腔镜组并发症率(24.7% vs 29.7%,P = 0.002)和术后住院时间(中位5天 vs 7天,P < 0.001)仍较低。

核心结论

  • 在肥胖非小细胞肺癌患者中,电视辅助胸腔镜肺叶切除术与开胸肺叶切除术相比,术后结局更优。
  • 因此,电视辅助胸腔镜手术应被视为肥胖人群的首选术式。

研究设计与样本

  • 研究为基于欧洲胸外科医师学会数据库的队列分析,收集2007年至2021年连续接受肺叶切除术且体重指数≥30的患者。
  • 共纳入13999例患者,其中电视辅助胸腔镜肺叶切除术5562例,开胸肺叶切除术8437例,采用意向性治疗分析。
  • 主要结局为并发症率、死亡率和术后住院时间,通过单变量、多变量校正和倾向性评分匹配分析评估差异。

主要发现

  • 电视辅助胸腔镜组并发症率低于开胸组(23.2% vs 30.2%,P < 0.001)。
  • 电视辅助胸腔镜组死亡率低于开胸组(0.8% vs 1.5%,P < 0.001)。
  • 电视辅助胸腔镜组术后住院时间短于开胸组(中位5天 vs 7天,P < 0.001)。
  • 倾向性评分匹配后,电视辅助胸腔镜组并发症率仍较低(24.7% vs 29.7%,P = 0.002),术后住院时间仍较短(中位5天 vs 7天,P < 0.001)。
  • 在重度肥胖亚组(体重指数35-39.9)和病态肥胖亚组(体重指数≥40)中,上述结果一致。

临床怎么用

  • 作者认为,电视辅助胸腔镜肺叶切除术应被视为肥胖非小细胞肺癌患者的首选术式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is a lack of evidence on whether perioperative outcomes differ in obese patients after video-assisted thoracic surgery (VATS) or open lobectomy. We queried the European Society of Thoracic Surgeons database to assess morbidity and postoperative length of hospital stay in obese patients submitted to VATS and open pulmonary lobectomy for non-small-cell lung cancer. METHODS: We collected all consecutive patients from 2007 to 2021 submitted to lobectomy through VATS or thoracotomy with a body mass index greater than or equal to 30. An intention-to-treat analysis was carried out. Primary outcomes were morbidity rate, mortality and postoperative length of stay (LOS). Differences in outcomes were assessed through univariable, multivariable-adjusted and propensity score-matched analysis. RESULTS: Out of a total of 78 018 patients submitted to lung lobectomy, 13 999 cases (17.9%) were considered in the analysis, including 5562 VATS lobectomies and 8437 thoracotomy lobectomies. The VATS group showed a lower complication rate (23.2% vs 30.2%, P < 0.001), mortality (0.8% vs 1.5%, P < 0.001) and postoperative LOS (median 5 vs 7 days, P < 0.001). After propensity score matching, the VATS approach confirmed a lower complication rate (24.7% vs 29.7%, P = 0.002) and postoperative LOS (median 5 vs 7 days, P < 0.001). Moreover, these results were consistently observed when analyzing the severe obese subgroup (body mass index 35-39.9) and morbid obese subgroup (body mass index ≥40). CONCLUSIONS: In obese patients with non-small cell lung cancer, VATS lobectomy was found to be associated with improved postoperative outcomes than open lobectomy. Consequently, it should be considered the approach of choice for the Obese population.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Guerrera F, Brunelli A, Falcoz PE, et al. Video-assisted thoracic surgery or thoracotomy for lung cancer surgery in obese patients? An analysis of the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2023. PMID: 37934142. doi:10.1093/ejcts/ezad368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。